Feel Therapeutics is developing digital biomarkers and therapeutics to bring objective data and measurement to the way we diagnose, manage, and care for mental health. Their mental health solutions include Feel Relief, a monthly digital subscription to reduce stress, promote sleep, and improve emotional wellbeing, Feel Program, a mental health patient support program combined with remote health monitoring, and Feel DTx, the world's first data-driven digital therapeutic to treat patients with Major Depressive Disorder (MDD) and/or Generalized Anxiety Disorder (GAD) through digital cognitive behavioral therapy (CBT), a health coach, and on-time interventions to deliver 24/7/365 mental health support to those at their point of need.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/23/22 | undisclosed |
SeedtoB Capital | undisclosed | |
| 01/09/24 | undisclosed | Venture |
Metavallon VC Satori Neuro SeedtoB Capital SOSV | undisclosed |
